Since the launch of human insulin product, protein-based therapies have found a prominent place in the biopharmaceutical industry. According to our new research report on Human Growth Hormone (HGH) Market, the global protein therapeutics industry holds tremendous growth potential and is estimated to cross the US$ 143 Billion-mark by 2015-end. The market for HGH has expanded greatly in the past few years due to increase in the number of approved indications, and is expected to touch new heights in the coming years.
Our new research report, “Human Growth Hormone Market Forecast to 2015”, says that the future of the global HGH market entirely depends upon the success/failure of biosimilars. The extensive study also discusses how the patent expirations are affecting the revenue patterns of branded HGH products. It analyzes the market’s current scenario, and presents forecast on the basis of drivers, challenges and regulatory developments.
The in-depth research finds that the United States is the largest market for HGH, followed by Europe and Japan, which enjoy a combined market share of over 50%. Our comprehensive report also studies the competitive landscape in order to help clients understand the market structure and its dynamics. Overall, the work aims at presenting a complete and comprehensible picture of the global HGH market to the clients.
